FDA

  • A line of people stand outside the Switzer Memorial Building in Washington, D.C.
    Image attribution tooltip
    Kevin Dietsch/Getty Images via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS layoffs characterized by confusion, errors

    The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions for some CMS employees to contact a director who died last year.

    By Rebecca Pifer • Updated 6 hours ago
  • Front sign of FDA building
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS layoffs could imperil medical device cybersecurity, Democrats say

    The FDA has 3,500 jobs on the chopping block, which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.

    By Emily Olsen • April 2, 2025
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendline➔
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • People wait in line outside of a glass door. A person in uniform holds a gloved hand to the door.
    Image attribution tooltip
    Kevin Dietsch via Getty Images
    Image attribution tooltip
    HHS overhaul

    ‘Just goodbyes and crying’: CDRH hit in HHS mass layoffs

    Teams working on communications and policy were cut from the agency on Tuesday, according to multiple FDA workers interviewed by MedTech Dive.

    By • April 2, 2025
  • Robert F. Kennedy Jr. stands in front of croded congressional room
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS begins layoffs in chaotic fashion

    The Trump administration sent out the first round of reduction-in-force notices early Tuesday morning, telling employees the cuts are necessary to improve efficiency.

    By Rebecca Pifer • April 1, 2025
  • A picture of a researcher standing in front of a testing machine in a laboratory.
    Image attribution tooltip
    Karen Ducey/Getty Images via Getty Images
    Image attribution tooltip

    Texas judge overturns FDA’s lab developed test regulation, siding with industry groups

    The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.

    By • April 1, 2025
  • A photo of FDA CBER Director Peter Marks delivering remarks at a public workshop on March 3, 2020.
    Image attribution tooltip
    Ermath, Michael. (2020). "Individualized Therapies Workshop" [Photograph]. Retrieved from Flickr.
    Image attribution tooltip

    Peter Marks, FDA’s top vaccine official, resigns

    In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed “misinformation and lies.”

    By Ned Pagliarulo • March 31, 2025
  • A flat hand holds up an at-home STI test against a white bakcground
    Image attribution tooltip
    Courtesy of Visby Medical
    Image attribution tooltip

    FDA OKs first at-home test for 3 STIs

    Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and trichomoniasis.

    By • March 31, 2025
  • RFK Jr. strides down a Capitol Hill hallway thronged by aides and reporters.
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip
    HHS overhaul

    ‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs

    Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were announced Thursday, sources said.

    By Sydney Halleman , Ned Pagliarulo , Rebecca Pifer • March 28, 2025
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom rejects claims of unauthorized device changes in FDA warning letter

    A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its glucose sensors.

    By • March 27, 2025
  • Robert F. Kennedy Jr., U.S. President Donald Trump’s nominee for Secretary of Health and Human Services departs after testifying in a confirmation hearing before the Senate Committee on Health, Education, Labor and Pensions at the Dirksen Senate Office Building on January 30, 2025 in Washington, D.C.
    Image attribution tooltip
    Kevin Dietsch/Getty Images via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS to cut 10,000 employees in major restructuring under RFK Jr.

    Advamed CEO Scott Whitaker said Thursday that “any reduction in force should be accompanied by policy and regulatory improvements that encourage innovation in medtech.”

    By Ned Pagliarulo , Rebecca Pifer , • Updated March 27, 2025
  • man in a navy suit with a red tie sits hands crossed at a desk with a microphone
    Image attribution tooltip
    Kayla Bartkowski via Getty Images
    Image attribution tooltip

    Makary confirmed by Senate as FDA commissioner

    The Johns Hopkins surgeon will helm the agency as layoffs loom and important decisions on treatments for rare and infectious diseases await.

    By Jonathan Gardner • March 26, 2025
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s FDA warning letter reveals unauthorized changes to sensors

    Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, according to the warning letter.

    By • March 26, 2025
  • A headband sits on a nightstand in front of a lamp
    Image attribution tooltip
    Courtesy of Beacon Biosignals
    Image attribution tooltip
    Deep Dive

    5 tips for building a predetermined change control plan

    The new framework is intended to make postmarket changes easier for products. Experts recommend having a clear roadmap and contacting regulators early.

    By • March 25, 2025
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott gets FDA nod to begin IVL trial after rivals buy up competition

    J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, and Boston Scientific agreed to buy Bolt Medical in January for up to $664 million.

    By • March 25, 2025
  • An image of two Smiths Medical white plastic implantable ProPort devices against a white background.
    Image attribution tooltip
    Retrieved from ICU Medical on March 21, 2025
    Image attribution tooltip

    Smiths Medical recalls port implants, warns on endotracheal tubes

    The business, acquired by ICU Medical in 2022, has been dealing with a series of recalls and quality issues over the past several years.

    By • March 21, 2025
  • FDA headquarters sign
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    FDA posts early alert after Calyxo urinary stone device tied to death

    The alert describes a problem that can lead to excessive pressure in the kidney during procedures to remove urinary stones.

    By • March 21, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic recalls embolization devices tied to 17 injuries, 4 deaths

    Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions for another model.

    By • March 19, 2025
  • Monogram Technologies' robotic surgery system is displayed against a gray background.
    Image attribution tooltip
    Permission granted by Monogram Technologies
    Image attribution tooltip

    Monogram robot wins FDA OK; Vicarious hit by supplier woes

    Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed supply chain issues for delaying its regulatory timeline.

    By • March 19, 2025
  • A sign for the FDA is displayed outside the agency's headquarters in Silver Spring, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Top device firms report safety data late: BMJ

    BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study found.

    By • March 18, 2025
  • Food And Drug Administration Headquarters In Maryland
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA adds hemodialysis devices to shortage list amid B. Braun disruption

    The disruption is expected to impact patient care, may require adjustments to the management of hemodialysis patients and could continue through the early fall of 2025.

    By • March 17, 2025
  • A flexible tube with a needle point is positioned in front of a hand holding a controller.
    Image attribution tooltip
    Retrieved from Screenshot: Johnson & Johnson on March 13, 2025
    Image attribution tooltip

    J&J’s Monarch robot wins FDA nod for AI software update

    Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.

    By • March 13, 2025
  • A sign reading Food and Drug Administration is seen above a door to a government building.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA accuses Mid-Link of copying or falsifying medical device test data

    The agency will reject all data from the Chinese service provider’s studies after Mid-Link failed to address concerns outlined in a warning letter last year, FDA officials said.

    By • March 12, 2025
  • FDA headquarters sign
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Douglas Kelly, deputy science director at FDA’s device center, leaves agency

    Kelly, who made several key hires at the CDRH and helped negotiate the last user fee agreement, announced his departure in a LinkedIn post Sunday.

    By • March 11, 2025
  • A CDC sign on the agency's exterior building
    Image attribution tooltip
    Jessica McGowan/Getty Images via Getty Images
    Image attribution tooltip

    The top 3 impacts of Trump’s health data purge

    Interrupted access to health-related data has already led to worse outcomes and could undermine faith in the U.S. healthcare system, experts say.

    By Michael Brady • March 10, 2025
  • Close up of a person's hands with a pulse oximeter clipped on their pointer finger.
    Image attribution tooltip
    FG Trade via Getty Images
    Image attribution tooltip

    New FDA pulse oximetry guidelines could stall under Trump

    The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts raised concerns that it might not be finalized.

    By • March 10, 2025